JP2002526407A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002526407A5 JP2002526407A5 JP2000573359A JP2000573359A JP2002526407A5 JP 2002526407 A5 JP2002526407 A5 JP 2002526407A5 JP 2000573359 A JP2000573359 A JP 2000573359A JP 2000573359 A JP2000573359 A JP 2000573359A JP 2002526407 A5 JP2002526407 A5 JP 2002526407A5
- Authority
- JP
- Japan
- Prior art keywords
- derivative
- ester
- salt
- pharmaceutical composition
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002148 esters Chemical class 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 239000008194 pharmaceutical composition Substances 0.000 description 6
- PUKLDDOGISCFCP-JSQCKWNTSA-N 21-Deoxycortisone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2=O PUKLDDOGISCFCP-JSQCKWNTSA-N 0.000 description 4
- FCYKAQOGGFGCMD-UHFFFAOYSA-N Fulvic acid Natural products O1C2=CC(O)=C(O)C(C(O)=O)=C2C(=O)C2=C1CC(C)(O)OC2 FCYKAQOGGFGCMD-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229940095100 fulvic acid Drugs 0.000 description 4
- 239000002509 fulvic acid Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 238000011200 topical administration Methods 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA98/9190 | 1998-10-08 | ||
| ZA989190 | 1998-10-08 | ||
| ZA99/2848 | 1999-04-21 | ||
| ZA992848 | 1999-04-21 | ||
| PCT/IB1999/001649 WO2000019999A1 (en) | 1998-10-08 | 1999-10-08 | Fulvic acid and its use in the treatment of various conditions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002526407A JP2002526407A (ja) | 2002-08-20 |
| JP2002526407A5 true JP2002526407A5 (enExample) | 2006-11-30 |
| JP4700808B2 JP4700808B2 (ja) | 2011-06-15 |
Family
ID=27144980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000573359A Expired - Fee Related JP4700808B2 (ja) | 1998-10-08 | 1999-10-08 | フルボ酸、および種々の状態の処置におけるその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6569900B1 (enExample) |
| EP (4) | EP1698333B1 (enExample) |
| JP (1) | JP4700808B2 (enExample) |
| AT (4) | ATE410160T1 (enExample) |
| AU (1) | AU766198B2 (enExample) |
| DE (4) | DE69939721D1 (enExample) |
| WO (1) | WO2000019999A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7896944B2 (en) * | 2004-06-23 | 2011-03-01 | Lone Knight Limited | Method for extracting fulvic acid molecules |
| RU2280458C1 (ru) * | 2004-11-30 | 2006-07-27 | Алевтина Ивановна Косолапова | Противовоспалительная мазь |
| ZA200705844B (en) * | 2004-12-15 | 2008-09-25 | Van Der Westhuzen Corne Floris | Detoxifying and immunity-booster composition |
| JP2006232785A (ja) * | 2005-02-28 | 2006-09-07 | Univ Of Tsukuba | フルボ酸を用いるｉ型アレルギー抑制剤及びｉ型アレルギーの発症抑制方法。 |
| US20080160111A1 (en) * | 2005-02-28 | 2008-07-03 | Hiroko Isoda | Type I Allergy Inhibitor and Methods of Inhibiting the Onset of Type I Allergy Using Fulvic Acid |
| US20070212434A1 (en) * | 2006-03-07 | 2007-09-13 | Day Kenneth S | Compositions and methods for human use containing fulvic acid |
| WO2007125492A2 (en) * | 2006-05-02 | 2007-11-08 | Pfeinsmith S.A. (Pty) Ltd | Acidic composition |
| BRPI0913586A8 (pt) | 2008-06-05 | 2018-03-13 | Pfeinsmith Ltd | combinação, e, uso de uma combinação. |
| DE102008058552A1 (de) | 2008-11-21 | 2010-05-27 | Mankau, Dieter, Prof. Dr. | Federrahmen und Federkörper zur Abstützung z. B. einer Matratze |
| GB0900786D0 (en) | 2009-01-19 | 2009-03-04 | Natracine Uk Ltd | Therapeutic compositions |
| GB0914966D0 (en) * | 2009-08-27 | 2009-09-30 | Natracine Uk Ltd | Fulvic acid compositions and their use |
| WO2013023062A1 (en) * | 2011-08-09 | 2013-02-14 | Wilford Lynn C | Antimicrobial agents and methods for use thereof in the abatement of food borne pathogenic organisms |
| IN2014DN07194A (enExample) * | 2012-03-07 | 2015-04-24 | Natracine Uk Ltd | |
| CN105246879A (zh) | 2013-05-28 | 2016-01-13 | 英派尔科技开发有限公司 | 腐植酸衍生物以及制备的方法和用途 |
| WO2014193337A1 (en) | 2013-05-28 | 2014-12-04 | Empire Technology Development Llc | Antioxidant humic acid derivatives and methods of preparation and use |
| EP3013367B1 (en) | 2013-06-28 | 2018-01-17 | Empire Technology Development LLC | Edible plasticizers for food and food packaging films |
| WO2017102565A1 (en) * | 2015-12-15 | 2017-06-22 | Rita Dobmeyer | Pharmaceutical composition comprising a fulvic acid and at least one boron-containing compound |
| US9820953B2 (en) | 2016-02-26 | 2017-11-21 | Omni Bioceutical Innovations, Inc. | Compositions of bioactive fulvate fractions and uses thereof |
| JP6120342B1 (ja) * | 2016-03-08 | 2017-04-26 | 株式会社スタイルアンドバリュージャパン | 美容組成物 |
| US20220160649A1 (en) * | 2019-03-20 | 2022-05-26 | Rita DOBMEYER | Pharmaceutical composition |
| EP3799854A1 (en) | 2019-10-01 | 2021-04-07 | Stefan Johannes Fellner | Extract of organic humified materials |
| WO2021226627A1 (en) * | 2020-05-05 | 2021-11-11 | Figene, Llc | Reduction of cytokine storm and pathological inflammation including caused by coronavirus using sphagnum and extracts thereof |
| KR102258006B1 (ko) * | 2020-12-22 | 2021-05-28 | 허교 | 풀빅산을 유효성분으로 포함하는 항바이러스 조성물 |
| CN117064913A (zh) * | 2023-02-23 | 2023-11-17 | 单士军 | 用于缓解特应性皮炎的黄腐酸外用制剂 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB244215A (en) | 1924-10-09 | 1925-12-17 | Richard William Bailey | Improvements in or relating to gas or oil power plant |
| DE2850685A1 (de) * | 1978-11-22 | 1980-06-04 | Kneer Franz X | Verfahren zur herstellung eines kolloiden schlammbades und schlammartiger pasten fuer die heilbehandlung |
| US5204368A (en) * | 1990-05-25 | 1993-04-20 | National Energy Council | Bacteriostatic and bacteriocidal method using fulvic acid derivatives |
| JPH0466508A (ja) * | 1990-07-03 | 1992-03-02 | Suntory Ltd | 抗菌剤 |
| JPH0687752A (ja) * | 1992-09-04 | 1994-03-29 | Kyowa Kagaku Kogyo Kk | 抗菌水及びこの抗菌水の製造方法 |
| CN1097990A (zh) * | 1994-01-29 | 1995-02-01 | 康宏盛 | 一种治疗股癣的药物 |
| JPH1017483A (ja) * | 1996-06-26 | 1998-01-20 | Keinzu Corp:Kk | 皮膚疾患予防及び治療剤 |
| NZ333440A (en) * | 1996-06-27 | 2000-04-28 | Organoflo Pty Ltd | A method of making a liquid fertilizing substance by mixing animal manure with a water soluble salt such as salts of magnesium, calcium, potassium or ammonium |
| JPH119674A (ja) * | 1997-06-25 | 1999-01-19 | M S K Planning:Kk | フミン酸を有効成分とする液体消臭剤と、その製造方法及びフミン酸を有効成分とした飲料用消臭剤と、その製造方法 |
| CN1103339C (zh) * | 1998-08-25 | 2003-03-19 | 祝亚勤 | 药用级泥炭黄腐植酸钠的制备方法 |
-
1999
- 1999-10-08 DE DE69939721T patent/DE69939721D1/de not_active Expired - Lifetime
- 1999-10-08 AU AU59923/99A patent/AU766198B2/en not_active Ceased
- 1999-10-08 EP EP06012243A patent/EP1698333B1/en not_active Expired - Lifetime
- 1999-10-08 JP JP2000573359A patent/JP4700808B2/ja not_active Expired - Fee Related
- 1999-10-08 EP EP06012245A patent/EP1700600B1/en not_active Expired - Lifetime
- 1999-10-08 EP EP99970022A patent/EP1126837B1/en not_active Expired - Lifetime
- 1999-10-08 AT AT06012245T patent/ATE410160T1/de not_active IP Right Cessation
- 1999-10-08 US US09/807,004 patent/US6569900B1/en not_active Expired - Lifetime
- 1999-10-08 WO PCT/IB1999/001649 patent/WO2000019999A1/en not_active Ceased
- 1999-10-08 DE DE69932939T patent/DE69932939T2/de not_active Expired - Lifetime
- 1999-10-08 AT AT99970022T patent/ATE336997T1/de not_active IP Right Cessation
- 1999-10-08 DE DE69939720T patent/DE69939720D1/de not_active Expired - Lifetime
- 1999-10-08 EP EP06012244A patent/EP1700599B1/en not_active Expired - Lifetime
- 1999-10-08 AT AT06012243T patent/ATE410158T1/de not_active IP Right Cessation
- 1999-10-08 DE DE69939722T patent/DE69939722D1/de not_active Expired - Lifetime
- 1999-10-08 AT AT06012244T patent/ATE410159T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002526407A5 (enExample) | ||
| EP0506207B1 (en) | Pharmaceutical vehicles for reducing transdermal flux | |
| ES2323395T3 (es) | Procedimiento y composicion para el tratamiento de irritaciones e infecciones epidermicas. | |
| CN101687002B (zh) | 葫芦巴的提取物 | |
| ATE401089T1 (de) | Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen | |
| JP2002524415A5 (enExample) | ||
| ATE455539T1 (de) | Darreichungsformen mit verlängerter wirkstofffreisetzung | |
| BR9807319A (pt) | Microgrânulos com liberação controlada, para administração oral, contendo cisplatina, processo de preparação dos mesmos, preparação farmacêutica, e, utilização dos microgrânulos. | |
| JP2015512386A5 (enExample) | ||
| DE69932939D1 (de) | Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen | |
| JP2010536745A5 (enExample) | ||
| RU2012149863A (ru) | Полисахарид семени тамаринда для применения в лечении микробных инфекций | |
| JP2022520665A (ja) | 液体プロポリス抽出物、その製剤およびその使用 | |
| CN105431154A (zh) | 抗菌成分 | |
| JP2009534306A5 (enExample) | ||
| EP1852114A4 (en) | COMPOSITION WITH DIHOMO (GAMMA) LINE ACIDIC ACID (DGLA) AS AN ACTIVE INGREDIENTS | |
| CN107582943B (zh) | 一种防治动物疥螨病的复方中药透皮喷雾剂及制备方法 | |
| ME02149B (me) | FORMULACIJE l METODE ZA LEČENJE AMILOIDOZE | |
| CN101259149A (zh) | 治疗脚气的酊剂 | |
| WO2000016786A3 (en) | Oxihumic acid and its use in the treatment of various conditions | |
| MXPA01007210A (es) | Agente para el tratamiento de enfermedad de parkinson que comprende un agente que mejora la funcion del astrocito como ingrediente activo. | |
| CN102614294A (zh) | 一种复方阿莫西林混悬注射剂及其制备方法 | |
| Semkina | Ointments, gels, liniments, and creams containing phytopreparations (a review) | |
| JP2002501901A5 (enExample) | ||
| WO2001045727A3 (en) | Stabilized veterinary compositions comprising more than one antiviral agent |